The purpose of this study is to learn about the experiences of cancer patients during treatment utilizing a mobile app called EveryDose© to track prescribed oral treatment for cancer. Based on these experiences, the study team will decide on expanding this pilot study to evaluate other methods that may prove to be beneficial in supporting cancer patient's ability to take cancer medications as prescribed (another common phrase used for this is adherence to treatment).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
25
Participants will use this application every day for up to 10 minutes, for up to 12 weeks. The purpose of the application is to improve medication adherence. Participants will receive an alert to the mobile device while at home to ensure medication was taken, and to serve as a medication log.
University of Miami
Miami, Florida, United States
RECRUITINGPercentage of patients who agree to use the EveryDose application
Percentage of patients who agree to use the EveryDose application
Time frame: up to 12 weeks
EveryDose application adherence measured by percentage
The percentage of weeks out of 12 week-period that the patient used the App (\> 50%)
Time frame: up to 12 weeks
Medication Adherence measured by dose ratio
Will be measured by the ratio of doses taken to the doses prescribed over a given time period.
Time frame: up to 12 weeks
Percentage of patient satisfaction measured by SUS
Percentage of patients who are satisfied with the EveryDose© mobile app (at least 80%) via the Systems Usability (SUS) survey by providers and patients. Survey asks patient about their satisfaction with the mobile application. Responses range from strongly disagree to strongly agree.
Time frame: 12 weeks (post intervention)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.